If anyone can explain to me what makes Robert and Jonathan Kraft’s opinion on Gov. Deval Patrick’s life sciences bill worth hearing, I’m all ears. The Krafts weighed in with an op-ed in yesterday’s Boston Globe, offering a full-throated endorsement of the governor’s $1 billion proposal to boost the life sciences in Massachusetts. Why don’t we have a series. Next we could have Terry Francona holding forth on standards-based education. Or maybe Manny on the economic multiplier effect of resort casinos.

The Krafts mention their own significant investment in the Patriots in the 1990s at a time when there was talk of the team decamping for Connecticut, and try to segue from that to the need for the state to make a similar big investment in life sciences. Seems like a bad example to bring up, though, since the Patriots drama involved a push by some for state money to help the team build stadium to keep them here, something we can thank former House speaker Tom Finneran for holding the line against. As we all know, the billionaire Krafts managed to build the thing on their own and didn’t move to Hartford after all. The only lesson one might draw from this is to let private business fund itself.

After you get the gist of their effort to draw parallels between their football business and stem cell research — which is ham-handed, at best, and shoots their own argument in the foot, at worst — the Krafts drop in this shocker:

Life sciences research and industry have a major economic impact on the region. It is growing significantly faster than other sectors, providing millions in tax revenues and thousands of high paying jobs. These jobs expand beyond research science and PhDs. The Kraft Group’s core businesses are in paper and packaging manufacturing and distribution. These industries and many others, like information technology, software, advanced materials, and construction benefit significantly from the growth of life sciences companies and facilities.

So it turns out pouring state money into biotech will actually be a boon to their core, non-football businesses. Well, that’s certainly a good reason support the biotech bill, isn’t it? Maybe the biotech bill is a good thing, maybe it isn’t. But let’s hope the conversation gets elevated a little beyond cheerleading from football team owners with an eye on boosting their cardboard box business.